Actively Recruiting
Validation of the French Version of the QASCI in Caregivers of Patients With COPD
Led by University Hospital, Brest · Updated on 2025-09-16
224
Participants Needed
2
Research Sites
85 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Brest
Lead Sponsor
C
Centre Hospitalier des Pays de Morlaix
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to validate the French version of the QASCI questionnaire, initially written and validated in Portuguese language by Hipolito et al., to assess caregiving burden in chronic obstructive pulmonary disease (COPD). The realization of this validation is significant on several levels. First, since COPD is a systemic condition, it affects not only the lungs but also many other organs and systems in the body. It leads to various complications that go beyond respiratory symptoms, creating major challenges not only physically but also in terms of participation and involvement for patients and their caregivers. The lack of validated tools in French to specifically assess the quality of life of caregivers in this context represents a gap that this study seeks to fill. This study is also justified by the fact that, although the QASCI has been validated in other languages and contexts, it is essential to linguistically and culturally adapt this tool for the French-speaking population. Validation in French is crucial to ensure the fidelity of the results obtained and the validity of the conclusions drawn from this instrument for caregivers of patients with COPD in France. In summary, this study addresses a specific need by contributing to the prevention of pathologies among caregivers. It enhances early detection and support for caregivers of patients with COPD while paving the way for future research on this often-overlooked population.
CONDITIONS
Official Title
Validation of the French Version of the QASCI in Caregivers of Patients With COPD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being a caregiver of a relative with COPD (according to the GOLD criteria)
- Being 18 years old or older
- The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month)
- Being a family member of the patient or living with the patient
- Being able to complete the French questionnaires
- Non-opposition statement provided
You will not qualify if you...
- Person under judicial protection (guardianship, curatorship, etc.)
- Refusal to participate
- The patient under the caregiver's care has experienced an exacerbation in the previous month
- The caregiver reports that the patient has cognitive impairments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Chu Brest
Brest, France, 29609
Actively Recruiting
2
Centre hospitalier de Morlaix
Morlaix, France, 29600
Actively Recruiting
Research Team
M
Marc BEAUMONT, PhD
CONTACT
A
Alan LE POUEZARD, physiotherapist
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here